[Comment] Time to overcome pretreatment HIV drug resistance

Antiretroviral therapy (ART) coverage among people living with HIV reached 53% worldwide in 2016, representing 21 million people on treatment.1 As the number of people accessing ART increases, the prevalence of pretreatment drug resistance has increased in several low-income and middle-income countries (LMICs).2 A recent WHO report showed that the prevalence of pretreatment resistance to non-nucleoside reverse transcriptase inhibitors (NNRTIs) surpassed 10% in six of 11 countries surveyed.3 Is this a threat for the UNAIDS target of eliminating HIV as a concern for public health by 2030?
Source: The Lancet Infectious Diseases - Category: Infectious Diseases Authors: Tags: Comment Source Type: research